Dr Chan Su Park , National Health Insurance Service Ilsan Hospital , South Korea
Dr. Chan Su Park, M.D., born on September 24, 1986, in Korea, is a distinguished gastroenterologist currently practicing at the National Health Insurance Service Ilsan Hospital. With a strong foundation in internal medicine and gastroenterology, he has dedicated his career to advancing clinical research and improving patient care in digestive diseases. His commitment to the field is evident through his extensive training at prestigious institutions, including Severance Hospital, Yonsei University. Dr. Park is recognized for his contributions to clinical trials and has published numerous studies in reputable journals, reflecting his expertise and dedication to enhancing treatment outcomes.
Publication Profile
Scopus
Strengths for the Award
Dr. Park’s extensive training, clinical experience, and active participation in groundbreaking research make him an exemplary candidate for the Best Researcher Award. His commitment to improving treatment methodologies and patient care demonstrates his dedication to the field.
Areas for Improvement
Continued collaboration with multidisciplinary teams could enhance his research scope and impact. Additionally, increasing engagement in public health initiatives could broaden his influence on gastrointestinal health awareness.
Education
Dr. Park earned his medical degree from Chungnam National University, College of Medicine, Daejeon, from March 2013 to February 2017. Following his graduation, he obtained licensure in medicine in February 2017 and completed his training in internal medicine by March 2021, securing a Diplomate status from the Korean Board of Internal Medicine. Additionally, he holds a subspecialty board certification in gastrointestinal endoscopy, underscoring his commitment to specialized training in gastroenterology.
Experience
Dr. Park’s clinical journey began with his internship at Severance Hospital, where he developed foundational skills in internal medicine from March 2017 to February 2018. He then completed a residency in internal medicine at the same institution, gaining hands-on experience from March 2018 to February 2020. Following his residency, he served as a research fellow in gastroenterology, contributing to significant studies from March 2021 to February 2022. As an instructor and now a doctor at National Health Insurance Service Ilsan Hospital, Dr. Park is actively involved in clinical practice and mentoring future medical professionals.
Research Focus
Dr. Park’s research primarily centers on advancing treatment protocols for gastrointestinal cancers and metabolic disorders. His work on pembrolizumab for advanced biliary tract cancer highlights his interest in immunotherapy. Additionally, he explores innovative techniques like photodynamic therapy for metabolic syndrome, showcasing his commitment to integrating novel approaches in clinical practice. Through these studies, Dr. Park aims to enhance understanding of disease mechanisms and improve patient outcomes in gastroenterology.
Publications Top Notes
- Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer 📄
- Highly Functional Duodenal Stent with Photosensitizers Enables Photodynamic Therapy for Metabolic Syndrome Treatment: Feasibility and Safety Study in a Porcine Model 🐖
- Phenotypic Characteristics of Circulating Tumor Cells and Predictive Impact for Efficacy of Chemotherapy in Patients with Pancreatic Cancer: A Prospective Study 📊
Conclusion
Dr. Chan Su Park’s exemplary qualifications, research contributions, and dedication to gastroenterology position him as a leading figure in his field, making him a deserving candidate for recognition as a Best Researcher.